We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle, Organon Pharma Pty Ltd, CON-882
Product name
NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle
Sponsor name
Organon Pharma Pty Ltd
Consent start
Consent no.
CON-882
Duration
The consent is effective for all batches of the products released from the 9 November 2021 until 30 June 2022.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The products do not conform with the requirement of Paragraph 8(1)(i) of
Therapeutic Goods Order No. 91 – Standard for labels of prescription and related
medicines in that the labels do not include the current sponsor details (Organon
Pharma Pty Ltd).
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines